About Contact Us Careers

Nonvenereal Syphilis Treatment Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3569
Published Date: Jul 24, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Nonvenereal Syphilis Treatment Landscape

Pfizer, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Novartis International AG
Sanofi S.A.
GlaxoSmithKline plc
Merck & Co., Inc.
Otsuka Pharmaceutical Co., Ltd.,
Abbott Laboratories
Cipla Limited

Browse Key Market Insights with Data Illustration:

Nonvenereal Syphilis Treatment Market Size & Share, Growth Analysis 2036

In the News

Cipla Limited a multinational pharmaceutical company joint hands with Kemwell Biopharma Private Limited, a leading global CDMO, to make cost-effective biotherapeutics.
Sandoz, a subsidiary of Novartis, expanded its portfolio in manufacturing antibiotics with the acquisition of the Cephalosporin antibiotics business of GSK.

Author Credits: Radhika Pawar

Report ID: 3569
Published Date: Jul 24, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of nonvenereal syphilis treatment is assessed at USD 329.34 Million.

The nonvenereal syphilis treatment market size was over USD 304.92 Million in 2023 and is expected to reach USD 923.74 Million by the end of 2036, growing at around 8.9% CAGR during the forecast period i.e., between 2024-2036. The rising cases of bejel as well as the increasing augmentation of infectious diseases are the major growth factors driving the growth of the market.

Middle East and Africa is likely to dominate majority industry share by 2036, attributed to existence of nonvenereal syphilis in regions of West Africa, the Mediterranean, and the Sahara propelled by lack of sanitization as well as the hot and humid climate.

Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis International AG, Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Cipla Limited

Inquiry Before Buying Request Free Sample